Document:

Exhibit 10.6

Exhibit 10.6

EXECUTION COPY

AMENDMENT NO. 3

Dated as of August 9, 2011

to

FIFTH AMENDED AND RESTATED

TRANSFER AND ADMINISTRATION AGREEMENT

Dated as of November 17, 2009

     THIS AMENDMENT NO. 3 (this “Amendment”) dated as of August 9, 2011 is entered into by
and among (i) NMC FUNDING CORPORATION, a Delaware corporation (the “Transferor”), (ii)
NATIONAL MEDICAL CARE, INC., a Delaware corporation, as collection agent (the “Collection
Agent”), (iii) the “Conduit Investors,” “Bank Investors” and “Administrative Agents” identified
on the signature pages hereto and (iv) WESTLB AG, NEW YORK BRANCH, as agent (the “Agent”).

PRELIMINARY STATEMENTS

          A. The Transferor, the Collection Agent, the Conduit Investors, the Bank Investors, the
Administrative Agents and the Agent are parties to that certain Fifth Amended and Restated Transfer
and Administration Agreement dated as of November 17, 2009 (as amended or otherwise modified prior
to the date hereof, the “TAA”). Capitalized terms used herein and not otherwise defined
shall have the meanings ascribed to them in the TAA.

          B. In addition, the parties hereto have agreed to amend the TAA on the terms and conditions
hereinafter set forth.

          NOW, THEREFORE, in consideration of the premises set forth above, and other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto
agree as follows:

          SECTION 1. Amendments to TAA. As of the Effective Date (as defined below), subject
to the conditions precedent set forth in Section 2 of this Amendment, the TAA is hereby
amended as follows:

          1.1 Extension. The definition of “Commitment Termination Date” in Section 1.1
of the TAA is hereby amended to change the date set forth therein from “September 27, 2011” to
“July 31, 2014”.

          1.2 Facility Limit. The definition of “Facility Limit” in Section 1.1 of the
TAA is hereby amended to change the dollar amount set forth therein from “$700,000,000” to
“$800,000,000”.

          1.3 Allocations. Schedule II (Commitments of Bank Investors) of the TAA is
amended and restated in its entirety to be in the form of Exhibit I hereto.

 

 

          1.4 Agreed Upon Procedures Report. Section 6.2(c) of the TAA is hereby
amended to change the date set forth therein from “September 30” to “June 30”.

          1.5 Certain Termination Events. Section 7.1 of the TAA is hereby amended to
delete clauses (k) and (l) thereof in their entirety and to substitute the
following new clauses therefor:

     (k) (i) any Liquidity Provider or Credit Support Provider shall have given
notice that an event of default has occurred and is continuing under any of its
respective agreements with a Conduit Investor in any Related Group and (ii)
Investors then holding not less than 66-2/3% of the aggregate Commitments in respect
of the unaffected Related Groups shall elect to declare such event a “Termination
Event”; or

     (l) (i) the Commercial Paper issued by a Conduit Investor in any Related Group
or its Related Issuer shall not be rated at least “A-2” by Standard & Poor’s or at
least “P-2” by Moody’s or (if rated by Fitch) at least F2 by Fitch, unless any
rating of such Commercial Paper shall be lower than such level solely as a result of
the correspondingly lower rating of the Credit Support Provider for such Conduit
Investor and (ii) Investors holding not less than 66-2/3% of the aggregate
Commitments in respect of the unaffected Related Groups shall elect to declare such
event a “Termination Event”; or

          1.6 Additional Amendments.

          (a) Section 1.1 of the TAA is further amended to delete the definitions therein of
“Agent Fee Letter”, “Investor Fee Letter” and “Related Group” and to substitute the following new
definitions therefor:

          “Agent Fee Letter” means the Second Amended and Restated Agent
Fee Letter dated August 9, 2011 between the Transferor and the Agent
relating to certain fees payable by the Transferor to the Agent hereunder,
as amended, restated, supplemented or otherwise modified from time to time.

          “Investor Fee Letter” means the Seventh Amended and Restated
Investor Fee Letter dated August 9, 2011 among the Transferor and the
Administrative Agents relating to certain fees payable by the Transferor to
the Administrative Agents, for the account of the Investors in their
respective Related Groups, as amended, restated, supplemented or otherwise
modified from time to time.

          “Related Group” means any of the following groups: (i) Compass,
as a Conduit Investor, and WestLB, as a Bank Investor and as an
Administrative Agent, together with their respective successors and
permitted assigns, (ii) Liberty Street, as a Conduit Investor, and
Scotiabank, as a Bank Investor and as Administrative Agent, together with
their respective successors and permitted assigns, (iii) Salisbury, as a

2

 

Conduit Investor and a Bank Investor, and Barclays as an Administrative
Agent, together with their respective successors and permitted assigns, (iv)
Atlantic Securitization, as a Conduit Investor, and Credit Agricole, as a
Bank Investor and as an Administrative Agent, together with their respective
successors and permitted assigns and (vi) Old Line, as a Conduit Investor,
and RBC, as a Bank Investor and as an Administrative Agent, together with
their respective successors and permitted assigns.

          (b) Each of the following Schedules and Exhibits to the TAA is amended and restated in its
entirety in the respective form identified below:

     (i) Schedule I (Notice Addresses of Bank Investors), to be in
the form of Exhibit II hereto;

     (ii) Exhibit H (List of Actions and Suits), to be in the form
of Exhibit III hereto;

     (iii) Exhibit Q (List of Transferring Affiliates), to be in the
form of Exhibit IV hereto.

          SECTION 2. Conditions Precedent. This Amendment shall become effective and be deemed
effective as of August 9, 2011 (the “Effective Date”) subject to the Agent’s receipt of the
following, each in form and substance satisfactory to each Administrative Agent:

          (a) counterparts of this Amendment duly executed by the Transferor, the Collection Agent, the
Conduit Investors, the Bank Investors, the Administrative Agents and the Agent;

          (b) a reaffirmation of the Parent Agreement, substantially in the form of Exhibit V
attached hereto, duly executed by each of FMCAG and FMCH;

          (c) confirmation that all fees due and payable on or before the Effective Date have been paid
in full;

          (d) to the extent requested by any Conduit Investor, such Conduit Investor shall have received
confirmation from each Rating Agency rating the Commercial Paper of such Conduit Investor or its
Related CP Issuer that the execution and delivery of this Amendment and the transactions
contemplated hereby will not result in the reduction or withdrawal of the then current rating of
the Commercial Paper issued by such Conduit Investor or its Related CP Issuer; and

          (e) a report by a firm of independent public accountants approved by each Administrative Agent
prepared in accordance with the procedures set forth in Exhibit T to the TAA and dated a
date not earlier than thirty (30) days prior to the date hereof; and

          (f) such other documents, instruments, certificates and opinions as the Agent or any
Administrative Agent shall reasonably request.

3

 

          SECTION 3. Covenants, Representations and Warranties of the Transferor and the Collection
Agent.

          3.1 Upon the effectiveness of this Amendment, each of the Transferor and the Collection Agent
hereby reaffirms all covenants, representations and warranties made by it in the TAA and agrees
that all such covenants, representations and warranties shall be deemed to have been remade as of
the Effective Date.

          3.2 Each of the Transferor and the Collection Agent hereby represents and warrants that (i)
this Amendment constitutes the legal, valid and binding obligation of such party, enforceable
against it in accordance with its terms and (ii) upon the effectiveness of this Amendment, no
Termination Event or Potential Termination Event shall exist under the TAA.

          SECTION 4. Reference to and Effect on the TAA.

          4.1 Unless otherwise indicated, all references in this Amendment to a specific “Section”,
“Schedule”, “Exhibit” and other subdivision are to such Section, Schedule, Exhibit or other
subdivision of the TAA.

          4.2 Upon the effectiveness of this Amendment, each reference in the TAA to “this Agreement,”
“hereunder,” “hereof,” “herein,” “hereby” or words of like import shall mean and be a reference to
the TAA as amended hereby, and each reference to the TAA in any other document, instrument and
agreement executed and/or delivered in connection with the TAA shall mean and be a reference to the
TAA as amended hereby.

          4.3 Except as specifically amended hereby, the TAA and all other documents, instruments and
agreements executed and/or delivered in connection therewith shall remain in full force and effect
and are hereby ratified and confirmed.

          4.4 The execution, delivery and effectiveness of this Amendment shall not operate as a waiver
of any right, power or remedy of any Investor, any Administrative Agent or the Agent under the TAA
or any other document, instrument, or agreement executed in connection therewith, nor constitute a
waiver of any provision contained therein.

          SECTION 5. Governing Law. THIS AMENDMENT SHALL BE GOVERNED AND CONSTRUED IN
ACCORDANCE WITH THE INTERNAL LAWS (AS OPPOSED TO THE CONFLICT OF LAW PROVISIONS) AND DECISIONS OF
THE STATE OF NEW YORK.

          SECTION 6. Execution in Counterparts. This Amendment may be executed in any number
of counterparts and by different parties hereto in separate counterparts, each of which when so
executed and delivered shall be deemed to be an original and all of which taken together shall
constitute but one and the same instrument. Delivery of an executed counterpart of this Amendment
by facsimile shall be equally as effective as delivery of an original executed counterpart of this
Amendment. Any party delivering an executed counterpart of this
Amendment by facsimile shall also deliver an original executed counterpart of this Amendment
but the failure to deliver an original executed counterpart shall not affect the validity,
enforceability and binding effect of this Amendment.

4

 

          SECTION 7. Headings. Section headings in this Amendment are included herein for
convenience of reference only and shall not constitute a part of this Amendment for any other
purpose.

[The remainder of this page intentionally left blank]

5

 

     IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their
respective officers thereunto duly authorized as of the date first written above.

	 	 	 	 	 

	 	 	NMC FUNDING CORPORATION,
	 	 	as Transferor
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Mark Fawcett
 
 Mark
Fawcett
	 

	 	Title:
	 	Vice President & Treasurer
	 
	 	 	NATIONAL MEDICAL CARE, INC., as
	 	 	Collection Agent
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Mark Fawcett
 
 Mark
Fawcett
	 

	 	Title:
	 	Vice President & Treasurer

Signature Page

Amendment No. 3 to Fifth Amended and Restated

Transfer and Administration Agreement

 

 

	 	 	 	 	 

	 	 	WESTLB AG, NEW YORK BRANCH, as Agent, an
	 	 	Administrative Agent and as a Bank Investor
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Matthew F. Tallo
 
 Matthew
F. Tallo
	 

	 	Title:
	 	Executive Director
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Vesselina Koleva
 
 Vesselina
Koleva
	 

	 	Title:
	 	Director
	 
	 	 	 	 
	 	 	COMPASS US ACQUISITION LLC,
	 	 	as a Conduit Investor
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Doris J. Hearn
 
 Doris
J. Hearn
	 

	 	Title:
	 	Vice President

Signature Page

Amendment No. 3 to Fifth Amended and Restated

Transfer and Administration Agreement

 

 

	 	 	 	 	 

	 	 	THE BANK OF NOVA SCOTIA, as an
	 	 	Administrative Agent and as a Bank Investor
	 
	 	 	 	 
	 

	 	By:

Name:

Title:
	 	/s/ John Frazell
 
John
Frazell 

Director
	 
	 	 	 	 
	 	 	LIBERTY STREET FUNDING LLC,
	 	 	as a Conduit Investor
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Jill A. Russo
 
Jill
A. Russo
	 

	 	Title:
	 	Vice President

Signature Page

Amendment No. 3 to Fifth Amended and Restated

Transfer and Administration Agreement

 

 

CREDIT AGRICOLE CORPORATE AND 
INVESTMENT BANK, NEW
YORK (f/k/a Calyon 
New York Branch), as an
Administrative Agent 
and as a Bank Investor

	 	 	 	 	 

	 

	 	By:

Name:
	 	/s/ Sam Pilcer
 
 Sam
Pilcer
	 

	 	Title:
	 	Managing Director
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Konstantina Kourmpetis
 
 Konstantina
Kourmpetis
	 

	 	Title:
	 	Managing Director

ATLANTIC ASSET SECURITIZATION LLC,

as a Conduit Investor

By: Credit Agricole Corporate and Investment Bank,

New York (f/k/a Calyon New York Branch), its

Attorney-in-Fact

	 	 	 	 	 

	 

	 	By:

Name:
	 	/s/ Sam Pilcer
 
 Sam
Pilcer
	 

	 	Title:
	 	Managing Director
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Konstantina Kourmpetis
 
 Konstantina
Kourmpetis
	 

	 	Title:
	 	Managing Director

Signature Page

Amendment No. 3 to Fifth Amended and Restated

Transfer and Administration Agreement

 

 

	 	 	 	 	 

	 	 	BARCLAYS BANK PLC, as an Administrative Agent
	 
	 	 	 	 
	 

	 	By:

Name:

Title:
	 	/s/ Jamie Pratt
 
Jamie
Pratt 

Director
	 
	 	 	 	 
	 	 	SALISBURY RECEIVABLES COMPANY, LLC,
	 	 	as a Conduit Investor and a Bank Investor
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ John McCarthy
 
 John
McCarthy
	 

	 	Title:
	 	Vice President

Signature Page

Amendment No. 3 to Fifth Amended and Restated

Transfer and Administration Agreement

 

 

	 	 	 	 	 

	 	 	ROYAL BANK OF CANADA, as an
	 	 	Administrative Agent and as a Bank Investor
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Janine D. Marsini
 
 Janine
D. Marsini
	 

	 	Title:
	 	Authorized Signatory
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Edward V. Westerman
 
 Edward
V. Westerman
	 

	 	Title:
	 	Authorized Signatory
	 
	 	 	 	 
	 	 	OLD LINE FUNDING, LLC,
	 	 	as a Conduit Investor
	 
	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Janine D. Marsini
 
 Janine
D. Marsini
	 

	 	Title:
	 	Authorized Signatory

Signature Page

Amendment No. 3 to Fifth Amended and Restated

Transfer and Administration Agreement

 

 

EXHIBIT I

Amended and Restated

Schedule II to the

Fifth Amended and Restated

Transfer and Administration Agreement

COMMITMENTS OF BANK INVESTORS

AND

RELATED GROUP LIMITS

COMMITMENTS OF BANK INVESTORS

	 	 	 	 	 
	Bank Investor	 	Commitment
	WestLB AG, New York Branch
	 	$	189,600,000.00	 
	The Bank of Nova Scotia
	 	$	164,000,000.00	 
	Credit Agricole Corporate and Investment Bank, New York
	 	$	164,000,000.00	 
	Salisbury Receivables Company, LLC
	 	$	141,200,000.00	 
	Royal Bank of Canada
	 	$	141,200,000.00	 
	TOTAL
	 	$	800,000,000.00	 

RELATED GROUP LIMITS

	 	 	 	 	 
	Conduit Investor	 	Related Group Limit
	Compass US Acquisition LLC
	 	$	189,600,000.00	 
	Liberty Street Funding LLC
	 	$	164,000,000.00	 
	Atlantic Asset Securitization LLC
	 	$	164,000,000.00	 
	Salisbury Receivables Company, LLC
	 	$	141,200,000.00	 
	Old Line Funding, LLC
	 	$	141,200,000.00	 
	TOTAL
	 	$	800,000,000.00	 

 

 

EXHIBIT II

Amended and Restated

Schedule I to the

Fifth Amended and Restated

Transfer and Administration Agreement

NOTICE ADDRESSES OF BANK INVESTORS

WESTLB AG, NEW YORK BRANCH

7 World Trade Center

250 Greenwich Street

New York, NY 10007

Attention: Asset Securitization Group

Telephone: (212) 852-6000

Telecopy: (212) 597-1423

With a copy to:

WESTLB AG, NEW YORK BRANCH

7 World Trade Center

250 Greenwich Street

New York, NY 10007

Attention: CMO Group

Telephone: (212) 597-1315

Fax: (212) 597-5459

Group Email: NYC_LPC@WestLB.com

THE BANK OF NOVA SCOTIA

Scotia Capital

711 Louisiana, Suite 1400

Houston, Texas 77002

Attention: John Frazell

Tel: 713-759-3426

Fax: 713-752-2425

Main: 713-759-0900

E-mail: john_frazell@scotiacapital.com

with a copy to:

The Bank of Nova Scotia

One Liberty Plaza

New York, NY 10006

Attention: Darren Ward

 

 

Tel: 212/225-5264

Fax: 212/225-5274

E-mail: darren_ward@scotiacapital.com

and

The Bank of Nova Scotia

One Liberty Plaza

New York, NY 10006

Attention: Vilma Pindling

Tel: 212/225-5410

Fax: 212/225-6465

E-mail: vilma_pidling@scotiacapital.com

SALISBURY RECEIVABLES COMPANY, LLC

c/o Barclays Capital

745 7th Avenue, 16 Floor

New York, NY, 10019

Attention: Mary Logan, Director, US Asset Securitization Group

Tel: 212/412-3266

E-mail: mary.logan@barcap.com

Notices of Incremental Transfers, notices or reductions to the Net Investment and monthly Investor
Reports should be sent to asgoperations@barclayscapital.com and
asgreports@barclayscapital.com

ROYAL BANK OF CANADA

1 Liberty Plaza, 5th Floor

New York, New York 10006

Attention: Tony Cowart

Tel: 212-428-6291

Fax: 212-428-2304

E-mail: conduit.funding@rbccm.com

CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK, NEW YORK

1301 Avenue of the Americas

New York, New York 10019

Attention: Roman Burt

Telephone: (212) 261-3996

Fax: (917) 849-5584

E-mail: roman.burt@ca-cib.com

with a copy to:

Credit Agricole Corporate and Investment Bank, New York

1301 Avenue of the Americas

2

 

New York, New York 10019

Attention: Bill Wood

Telephone: (212) 261-7808

Fax: (917) 849-5584

E-mail: bill.wood@ca-cib.com

2

 

EXHIBIT III

Amended and Restated

Exhibit H to the

Fifth Amended and Restated

Transfer and Administration Agreement

LIST OF ACTIONS AND SUITS

Such actions and suits as are identified in the “Legal Proceedings” section of the most recent
annual report as of the date hereof on Form 20-F or report on Form 6-K for the quarter most
recently ended prior to the date hereof, as applicable, filed by Fresenius Medical Care AG & Co.
KGaA with the U.S. Securities and Exchange Commission (“SEC”) under the Securities Exchange Act of
1934, which sections are hereby incorporated by reference as if fully set forth herein.

Such filings can be found on the SEC website at the following link:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001333141&owner=exclude&count=40

 

 

EXHIBIT IV

Amended and Restated

Exhibit Q to the

Fifth Amended and Restated

Transfer and Administration Agreement

LIST OF TRANSFERRING AFFILIATES

APHERESIS CARE GROUP, INC.

BIO MEDICAL APPLICATIONS MANAGEMENT COMPANY, INC.

BIO-MEDICAL APPLICATIONS OF ALABAMA, INC.

BIO-MEDICAL APPLICATIONS OF AMARILLO, INC.

BIO-MEDICAL APPLICATIONS OF ANACOSTIA, INC.

BIO-MEDICAL APPLICATIONS OF AQUADILLA, INC.

BIO-MEDICAL APPLICATIONS OF ARECIBO, INC.

BIO-MEDICAL APPLICATIONS OF ARKANSAS, INC.

BIO-MEDICAL APPLICATIONS OF BAYAMON, INC.

BIO-MEDICAL APPLICATIONS OF BLUE SPRINGS, INC

BIO-MEDICAL APPLICATIONS OF CAGUAS, INC.

BIO-MEDICAL APPLICATIONS OF CALIFORNIA, INC.

BIO-MEDICAL APPLICATIONS OF CAMARILLO, INC.

BIO-MEDICAL APPLICATIONS OF CAPITOL HILL, INC.

BIO-MEDICAL APPLICATIONS OF CAROLINA, INC.

BIO-MEDICAL APPLICATIONS OF CARSON, INC.

BIO-MEDICAL APPLICATIONS OF CLINTON, INC.

BIO-MEDICAL APPLICATIONS OF COLUMBIA HEIGHTS, INC.

BIO-MEDICAL APPLICATIONS OF CONNECTICUT, INC.

BIO-MEDICAL APPLICATIONS OF DELAWARE, INC.

BIO-MEDICAL APPLICATIONS OF DOVER, INC.

BIO-MEDICAL APPLICATIONS OF EUREKA, INC.

BIO-MEDICAL APPLICATIONS OF FAYETTEVILLE, INC.

BIO-MEDICAL APPLICATIONS OF FLORIDA, INC.

BIO-MEDICAL APPLICATIONS OF FREMONT, INC.

BIO-MEDICAL APPLICATIONS OF FRESNO, INC.

BIO-MEDICAL APPLICATIONS OF GEORGIA, INC.

BIO-MEDICAL APPLICATIONS OF GUAYAMA, INC.

BIO-MEDICAL APPLICATIONS OF HUMACAO, INC.

BIO-MEDICAL APPLICATIONS OF ILLINOIS, INC.

BIO-MEDICAL APPLICATIONS OF INDIANA, INC.

BIO-MEDICAL APPLICATIONS OF KANSAS, INC.

BIO-MEDICAL APPLICATIONS OF KENTUCKY, INC.

BIO-MEDICAL APPLICATIONS OF LONG BEACH, INC.

BIO-MEDICAL APPLICATIONS OF LOS GATOS, INC.

 

 

BIO-MEDICAL APPLICATIONS OF LOUISIANA, LLC

BIO-MEDICAL APPLICATIONS OF MAINE, INC.

BIO-MEDICAL APPLICATIONS OF MANCHESTER, INC.

BIO-MEDICAL APPLICATIONS OF MARYLAND, INC.

BIO-MEDICAL APPLICATIONS OF MASSACHUSETTS, INC.

BIO-MEDICAL APPLICATIONS OF MAYAGUEZ, INC.

BIO-MEDICAL APPLICATIONS OF MICHIGAN, INC.

BIO-MEDICAL APPLICATIONS OF MINNESOTA, INC.

BIO-MEDICAL APPLICATIONS OF MISSION HILLS, INC.

BIO-MEDICAL APPLICATIONS OF MISSISSIPPI, INC.

BIO-MEDICAL APPLICATIONS OF MISSOURI, INC.

BIO-MEDICAL APPLICATIONS OF NEVADA, INC

BIO-MEDICAL APPLICATIONS OF NEW HAMPSHIRE, INC.

BIO-MEDICAL APPLICATIONS OF NEW JERSEY, INC.

BIO-MEDICAL APPLICATIONS OF NEW MEXICO, INC.

BIO-MEDICAL APPLICATIONS OF NORTH CAROLINA, INC.

BIO-MEDICAL APPLICATIONS OF NORTHEAST, D.C., INC.

BIO-MEDICAL APPLICATIONS OF OAKLAND, INC.

BIO-MEDICAL APPLICATIONS OF OHIO, INC.

BIO-MEDICAL APPLICATIONS OF OKLAHOMA, INC.

BIO-MEDICAL APPLICATIONS OF PENNSYLVANIA, INC.

BIO-MEDICAL APPLICATIONS OF PONCE, INC.

BIO-MEDICAL APPLICATIONS OF PUERTO RICO, INC.

BIO-MEDICAL APPLICATIONS OF RHODE ISLAND, INC.

BIO-MEDICAL APPLICATIONS OF RIO PIEDRAS, INC.

BIO-MEDICAL APPLICATIONS OF SAN ANTONIO, INC.

BIO-MEDICAL APPLICATIONS OF SAN GERMAN, INC.

BIO-MEDICAL APPLICATIONS OF SAN JUAN, INC.

BIO-MEDICAL APPLICATIONS OF SOUTH CAROLINA, INC.

BIO-MEDICAL APPLICATIONS OF SOUTHEAST WASHINGTON, INC.

BIO-MEDICAL APPLICATIONS OF TENNESSEE, INC.

BIO-MEDICAL APPLICATIONS OF TEXAS, INC.

BIO-MEDICAL APPLICATIONS OF THE DISTRICT OF COLUMBIA, INC.

BIO-MEDICAL APPLICATIONS OF UKIAH, INC.

BIO-MEDICAL APPLICATIONS OF VIRGINIA, INC.

BIO-MEDICAL APPLICATIONS OF WEST VIRGINIA, INC.

BIO-MEDICAL APPLICATIONS OF WISCONSIN, INC.

BIO-MEDICAL APPLICATIONS OF WOONSOCKET, INC.

BIO-MEDICAL APPLICATIONS OF WYOMING, LLC

BREVARD COUNTY DIALYSIS, LLC

CLAYTON COUNTY DIALYSIS, LLC

CLERMONT DIALYSIS CENTER, LLC

COLUMBUS AREA RENAL ALLIANCE, LLC

CONEJO VALLEY DIALYSIS, INC.

DIALYSIS AMERICA GEORGIA, LLC

DIALYSIS ASSOCIATES OF NORTHERN NEW JERSEY, L.L.C.

2

 

DIALYSIS ASSOCIATES, LLC

DIALYSIS CENTERS OF AMERICA ILLINOIS, INC.

DIALYSIS MANAGEMENT CORPORATION

DIALYSIS SERVICES OF ATLANTA, INC.

DIALYSIS SERVICES OF CINCINNATI, INC.

DIALYSIS SERVICES OF SOUTHEAST ALASKA, LLC

DIALYSIS SERVICES, INC.

DIALYSIS SPECIALISTS OF MARIETTA, LTD.

DIALYSIS SPECIALISTS OF TOPEKA, INC.

DIALYSIS SPECIALISTS OF TULSA, INC.

DOUGLAS COUNTY DIALYSIS, LLC

DOYLESTOWN ACUTE RENAL SERVICES, L.L.C.

DU PAGE DIALYSIS, LTD.

EVEREST HEALTHCARE HOLDINGS, INC.

EVEREST HEALTHCARE INDIANA, INC.

EVEREST HEALTHCARE OHIO, INC.

EVEREST HEALTHCARE RHODE ISLAND, INC.

EVEREST HEALTHCARE TEXAS HOLDING CORP.

EVEREST HEALTHCARE TEXAS, L.P.

FMS DELAWARE DIALYSIS, LLC

FMS PHILADELPHIA DIALYSIS, LLC

FONDREN DIALYSIS CLINIC, INC.

FORT SCOTT REGIONAL DIALYSIS CENTER, INC.

FOUR STATE REGIONAL DIALYSIS CENTER, INC.

FRESENIUS HEALTH PARTNERS CARE SYSTEMS, INC. (F/K/A RENAISSANCE HEALTH CARE, INC.)

FRESENIUS HEALTH PARTNERS, INC. (F/K/A FRESENIUS MEDICAL CARE HEALTH PLAN, INC.)

FRESENIUS MANAGEMENT SERVICES, INC.

FRESENIUS MEDICAL CARE APHERESIS SERVICES, LLC

FRESENIUS MEDICAL CARE COMPREHENSIVE CKD SERVICES, INC.

FRESENIUS MEDICAL CARE HARSTON HALL, LLC

FRESENIUS MEDICAL CARE HEALTHCARE RECRUITMENT, LLC

FRESENIUS MEDICAL CARE HOLDINGS, INC.

FRESENIUS MEDICAL CARE OF ILLINOIS, LLC

FRESENIUS MEDICAL CARE OF MONTANA, LLC

FRESENIUS MEDICAL CARE — OSUIM KIDNEY CENTERS, LLC

FRESENIUS MEDICAL CARE PHARMACY SERVICES, INC.

FRESENIUS MEDICAL CARE PSO, LLC

FRESENIUS MEDICAL CARE RX, LLC

FRESENIUS MEDICAL CARE — SOUTH TEXAS KIDNEY, LLC

FRESENIUS MEDICAL CARE VENTURES HOLDING COMPANY, INC.

FRESENIUS MEDICAL CARE VENTURES, LLC

FRESENIUS MEDICAL CARE DIALYSIS SERVICES COLORADO LLC (F/K/A BIO MEDICAL APPLICATIONS OF COLORADO, INC.

FRESENIUS MEDICAL CARE DIALYSIS SERVICES OREGON, LLC

2

 

FRESENIUS USA MANUFACTURING, INC.

FRESENIUS USA MAKETING, INC.

FRESENIUS USA, INC

FRESENIUS VASCULAR CARE, INC. (F/K/A NATIONAL VASCULAR CARE, INC.

GULF REGION MOBILE DIALYSIS, INC.

HAEMO-STAT, INC.

HEALTH IT SERVICES GROUP, LLC

HENRY DIALYSIS CENTER, LLC

HOLTON DIALYSIS CLINIC, LLC

HOME DIALYSIS OF AMERICA, INC.

HOME DIALYSIS OF MUHLENBERG COUNTY, INC.

HOMESTEAD ARTIFICIAL KIDNEY CENTER, INC.

INLAND NORTHWEST RENAL CARE GROUP, LLC

INTEGRATED RENAL CARE OF THE PACIFIC, LLC

JEFFERSON COUNTY DIALYSIS, INC.

KDCO, INC.

KENTUCKY RENAL CARE GROUP, LLC

LAWTON DIALYSIS, INC.

LITTLE ROCK DIALYSIS, INC.

MAUMEE DIALYSIS SERVICES, LLC

METRO DIALYSIS CENTER — NORMANDY, INC.

METRO DIALYSIS CENTER — NORTH, INC.

MIAMI REGIONAL DIALYSIS CENTER, INC.

MICHIGAN HOME DIALYSIS CENTER, INC.

NATIONAL MEDICAL CARE, INC.

NATIONAL NEPHROLOGY ASSOCIATES MANAGEMENT COMPANY OF TEXAS, INC

NATIONAL NEPHROLOGY ASSOCIATES OF TEXAS, L.P.

NEPHROMED LLC

NEW YORK DIALYSIS SERVICES, INC.

NMC SERVICES, INC.

NNA MANAGEMENT COMPANY OF KENTUCKY, INC.

NNA MANAGEMENT COMPANY OF LOUISIANA, INC.

NNA OF ALABAMA, INC.

NNA OF EAST ORANGE, L.L.C.

NNA OF FLORIDA, LLC

NNA OF GEORGIA, INC.

NNA OF HARRISON, L.L.C.

NNA OF LOUISIANA, LLC

NNA OF NEVADA, INC.

NNA OF OKLAHOMA, INC.

NNA OF OKLAHOMA, L.L.C.

NNA OF RHODE ISLAND, INC.

NNA OF TOLEDO, INC.

NNA-SAINT BARNABAS LIVINGSTON, L.L.C.

NNA-SAINT BARNABAS, L.L.C.

NORCROSS DIALYSIS CENTER, LLC

2

 

NORTH BUCKNER DIALYSIS CENTER, INC.

NORTHEAST ALABAMA KIDNEY CLINIC, INC.

NORTHERN NEW JERSEY DIALYSIS, L.L.C.

PHYSICIANS DIALYSIS COMPANY, INC.

QUALICENTERS, INC.

QUALICENTERS ALBANY, LTD.

QUALICENTERS BEND, LLC

QUALICENTERS COOS BAY, LTD.

QUALICENTERS EUGENE-SPRINGFIELD LTD.

QUALICENTERS INLAND NORTHWEST LLC

QUALICENTERS PUEBLO, LLC

QUALICENTERS SALEM, LLC

QUALICENTERS SIOUX CITY LLC

RCG BLOOMINGTON, LLC

RCG EAST TEXAS, LLP

RCG INDIANA, L.L.C.

RCG IRVING, LLP

RCG MARTIN, LLC

RCG MEMPHIS EAST, LLC

RCG MEMPHIS, LLC

RCG MISSISSIPPI, INC.

RCG PENSACOLA, LLC

RCG ROBSTOWN, LLP

RCG UNIVERSITY DIVISION, IN.

RCG WEST HEALTH SUPPLY, L.C

RENAL CARE GROUP ALASKA, INC.

RENAL CARE GROUP EAST, INC.

RENAL CARE GROUP MICHIGAN, INC.

RENAL CARE GROUP NORTHWEST, INC.

RENAL CARE GROUP OF THE MIDWEST, INC.

RENAL CARE GROUP OF THE OZARKS, LLC

RENAL CARE GROUP OF THE ROCKIES, LLC

RENAL CARE GROUP OF THE SOUTH, INC.

RENAL CARE GROUP OF THE SOUTHEAST, INC.

RENAL CARE GROUP OHIO, INC.

RENAL CARE GROUP SOUTHWEST MICHIGAN, LLC

RENAL CARE GROUP SOUTH NEW MEXICO, LLC

RENAL CARE GROUP SOUTHWEST HOLDINGS, INC.

RENAL CARE GROUP SOUTHWEST, L.P.

RENAL CARE GROUP TERRE HAUTE, LLC

RENAL CARE GROUP TEXAS, INC.

RENAL CARE GROUP TOLEDO, LLC

RENAL CARE GROUP WESTLAKE, LLC

RENAL CARE GROUP, INC.

RENAL CARE GROUP-HARLINGEN, L.P.

RENAL SOLUTIONS, INC.

2

 

RENALPARTNERS, INC.

RENEX CORP.

RENEX DIALYSIS CLINIC OF BLOOMFIELD, INC.

RENEX DIALYSIS CLINIC OF BRIDGETON, INC.

RENEX DIALYSIS CLINIC OF CREVE COEUR, INC.

RENEX DIALYSIS CLINIC OF DOYLESTOWN, INC.

RENEX DIALYSIS CLINIC OF MAPLEWOOD, INC.

RENEX DIALYSIS CLINIC OF ORANGE, INC.

RENEX DIALYSIS CLINIC OF PHILADELPHIA, INC.

RENEX DIALYSIS CLINIC OF PITTSBURGH, INC.

RENEX DIALYSIS CLINIC OF SOUTH GEORGIA, INC.

RENEX DIALYSIS CLINIC OF ST. LOUIS, INC.

RENEX DIALYSIS CLINIC OF TAMPA, INC.

RENEX DIALYSIS CLINIC OF UNION, INC.

RENEX DIALYSIS CLINIC OF UNIVERSITY CITY, INC.

RENEX DIALYSIS CLINIC OF WOODBURY, INC.

RENEX DIALYSIS FACILITIES, INC.

ROSS DIALYSIS — ENGLEWOOD, LLC

S.A.K.D.C., INC.

SAINT LOUIS RENAL CARE, LLC

SAN DIEGO DIALYSIS SERVICES, INC.

SANTA BARBARA COMMUNITY DIALYSIS CENTER

SMYRNA DIALYSIS CENTER, LLC

SORB TECHNOLOGY, INC.

SPECTRA DIAGNOSTICS, LLC

SPECTRA EAST, INC.

SPECTRA LABORATORIES, INC.

SPECTRA MEDICAL DATA PROCESSING, LLC

SPECTRA RENAL RESEARCH, LLC

SSKG, INC.

ST. LOUIS REGIONAL DIALYSIS CENTER, INC.

STAT DIALYSIS CORPORATION

STONE MOUNTAIN DIALYSIS CENTER, LLC

STUTTGART DIALYSIS, LLC

TAPPAHANNOCK DIALYSIS CENTER, INC

TERRELL DIALYSIS CENTER, L.L.C.

THREE RIVERS DIALYSIS SERVICES, LLC

U.S. VASCULAR ACCESS HOLDINGS, LLC

WARRENTON DIALYSIS FACILITY, INC.

WEST END DIALYSIS CENTER, INC.

WEST PALM DIALYSIS, LLC

WHARTON DIALYSIS, INC.

WSKC DIALYSIS SERVICES, INC.

2

 

EXHIBIT V

FORM OF

REAFFIRMATION OF PARENT AGREEMENT

August 9, 2011

	 	 	 

	WestLB, AG, New York Branch, 

as Administrative Agent and Agent 

7 World Trade Center 

250 Greenwich Street 

New York, NY 10007

	 	Barclays Bank PLC

as Administrative Agent

745 7th Avenue, 16 Floor

New York, NY, 10019
	 
	 	 
	Credit Agricole Corporate and Investment 
Bank,
New York, as Administrative Agent 

1301 Avenue of the Americas 

New York, New York 10019

	 	Royal Bank of Canada 

as Administrative Agent 

1 Liberty Plaza, 5th Floor 

New York, New York 10006
	 
	 	 
	The Bank of Nova Scotia 

as Administrative Agent 

711 Louisiana, Suite 1400

Houston, Texas 77002
	 	 

Each of the undersigned, Fresenius Medical Care AG & Co. KGaA and FRESENIUS MEDICAL CARE HOLDINGS,
INC. (i) acknowledges, and consents to, the execution of that certain Amendment No. 3, dated as of
August 9, 2011 (the “TAA Amendment”) with respect to the Fifth Amended and Restated
Transfer and Administration Agreement, dated as of November 17, 2009, in each case among NMC
Funding Corporation, National Medical Care, Inc., the entities parties thereto as “Conduit
Investors”, the financial institutions parties thereto as “Bank Investors”, the
financial institutions parties thereto as “Administrative Agents” and WestLB AG, New York
Branch, as “Agent”, together with the other instruments, documents and agreements
referenced in Section 2 of the TAA Amendment (collectively, the “Amendment Documents”),
(iii) reaffirms all of its obligations under that certain Amended and Restated Parent Agreement
dated as of October 16, 2008 made by the undersigned (as amended or otherwise modified from time to
time, the “Parent Agreement”), and (iv) acknowledges and agrees that, after giving effect
to the TAA Amendment and the other Amendment Documents, such Parent Agreement remains in full force
and effect and such Parent Agreement is hereby ratified and confirmed.

2

 

	 	 	 	 	 	 	 

	FRESENIUS	 	MEDICAL CARE HOLDINGS, INC.	 	FRESENIUS MEDICAL CARE AG
	 	 	 	 	& Co. KGaA
	 	 	 	 	represented by
	 	 	 	 	Fresenius Medical Care Management AG
	 	 	 	 	(General Partner)
	 
	 	 	 	 	 	 
	By: 

Name:

	 	/s/ Mark Fawcett
 
 Mark
Fawcett
	 	By:

Name:
	 	/s/ Dr. Ben Lipps
 
 Dr. Ben
Lipps
	Title:

	 	Vice President &Asst.
Treasurer
	 	Title:
	 	Member of the Management Board CEO
	 
	 	 	 	 	 	 
	 

	 	 	 	By:

Name:
	 	/s/ Dr. Rainer Runte
 
 Dr. Rainer
Runte
	 

	 	 	 	Title:
	 	Member of the Management Board CAO

2Exhibit 10.7

Exhibit 10.7

EXECUTION COPY

AMENDMENT NO. 3

Dated as of August 9, 2011

to

AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

Dated as of October 16, 2008

          THIS AMENDMENT No. 3 (this “Amendment”) dated as of August 9, 2011 is entered into by
and between NMC FUNDING CORPORATION, a Delaware corporation, as Purchaser (the “Purchaser”)
and NATIONAL MEDICAL CARE, INC., a Delaware corporation, as Seller (the “Seller”).

PRELIMINARY STATEMENTS

          A. The Purchaser and the Seller are parties to that certain Amended and Restated Receivables
Purchase Agreement dated as of October 16, 2008 (as amended or otherwise modified prior to the date
hereof, the “RPA”). Capitalized terms used herein and not otherwise defined shall have the
meanings ascribed to them in the RPA.

          B. The Purchaser and the Seller have agreed to amend the RPA on the terms and conditions
hereinafter set forth.

          NOW, THEREFORE, in consideration of the premises set forth above, and other good and valuable
consideration the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree
as follows:

          SECTION 1. Amendments.

          1.1. Section 1.1 of the RPA is hereby amended by deleting the definition of “BMA Transfer
Agreement” in its entirety and replacing it with the following:

     “BMA Transfer Agreement” means that certain Receivables Purchase
Agreement dated as of August 28, 1997 by and between BMA, as seller, and the Seller,
as purchaser, as the same may be amended, restated, supplemented or otherwise
modified from time to time.

          1.2. Section 3.1 of the RPA is hereby amended to add the following provision as new clause (z)
thereof:

     (z) Leased Equipment. With respect to any dialysis or other medical
equipment that has been leased by any Person to the Seller in respect of which such
lessor has filed a UCC financing statement against the Seller (“Subject Leased
Equipment”), (i) the arrangement relating to such Subject Leased Equipment is

 

 

intended in good faith by such lessor and the Seller to be an
“operating lease” and not a secured financing; (ii) the collateral covered by each
such UCC financing statement is limited to the applicable Subject Leased Equipment
and its proceeds; (iii) less than five percent (5.0%) of the Subject Leased
Equipment is retained by the Seller, with the balance of the Subject Leased
Equipment being used by Transferring Affiliates (and other affiliates that are not
Transferring Affiliates) under unsecured intercompany usage or subleasing
arrangements between the Seller and such Transferring Affiliates (or such other
affiliates); and (iv) neither the Seller nor any lessor of Subject Leased Equipment
has filed any UCC financing statement or similar instrument against any Transferring
Affiliate in respect of any Subject Leased Equipment.

          1.3 Exhibit F (List of Actions and Suits) of the RPA is amended to delete the exhibit in its
entirety and to substitute therefor the “Exhibit F” attached hereto as Exhibit 1.

          1.4. Exhibit J (List of Transferring Affiliates, Chief Executive Offices of Transferring
Affiliates and Tradenames) of the RPA is amended to delete the exhibit in its entirety and to
substitute therefor the “Exhibit J” attached hereto as Exhibit 2.

          SECTION 2. Conditions Precedent. This Amendment shall become effective and be deemed
effective as of the date hereof upon (i) the receipt by the Purchaser of counterparts of this
Amendment duly executed by the Purchaser and the Seller and (ii) the effectiveness of Amendment No.
3 to the Fifth Amended and Restated Transfer and Administration Agreement of even date herewith
among the Purchaser, as “Transferor”, the Seller, as the initial “Collection Agent” thereunder, the
Persons parties thereto as “Conduit Investors”, the Persons parties thereto as “Bank Investors”,
the Persons parties thereto as “Administrative Agents” and WestLB AG, New York Branch, as “Agent”.

          SECTION 3. Covenants, Representations and Warranties of the Seller.

          3.1 Upon the effectiveness of this Amendment, the Seller hereby reaffirms all covenants,
representations and warranties made by it in the RPA and agrees that all such covenants,
representations and warranties shall be deemed to have been remade as of the effective date of this
Amendment.

          3.2 The Seller hereby represents and warrants that (i) this Amendment constitutes the legal,
valid and binding obligation of such party, enforceable against it in accordance with its terms and
(ii) upon the effectiveness of this Amendment, no Seller Default or Potential Seller Default shall
exist under the RPA.

          SECTION 4. Reference to and Effect on the RPA.

          4.1 Upon the effectiveness of this Amendment, each reference in the RPA to “this Agreement,”
“hereunder,” “hereof,” “herein,” “hereby” or words of like import shall mean and be a reference to
the RPA as amended hereby, and each reference to the RPA in any other document,

2

 

instrument and agreement executed and/or delivered in connection with the RPA shall
mean and be a reference to the RPA as amended hereby.

          4.2 Except as specifically amended hereby, the RPA and all other documents, instruments and
agreements executed and/or delivered in connection therewith shall remain in full force and effect
and are hereby ratified and confirmed.

          4.3 The execution, delivery and effectiveness of this Amendment shall not operate as a waiver
of any right, power or remedy of the Purchaser or any of its assignees under the RPA or any other
document, instrument, or agreement executed in connection therewith, nor constitute a waiver of any
provision contained therein.

          SECTION 5. Governing Law. THIS AMENDMENT SHALL BE GOVERNED AND CONSTRUED IN
ACCORDANCE WITH THE INTERNAL LAWS (AS OPPOSED TO THE CONFLICT OF LAW PROVISIONS) AND DECISIONS OF
THE STATE OF NEW YORK.

          SECTION 6. Execution in Counterparts. This Amendment may be executed in any number
of counterparts and by different parties hereto in separate counterparts, each of which when so
executed and delivered shall be deemed to be an original and all of which taken together shall
constitute but one and the same instrument. Delivery of an executed counterpart via facsimile or
other electronic transmission shall be deemed delivery of an original counterpart.

          SECTION 7. Headings. Section headings in this Amendment are included herein for
convenience of reference only and shall not constitute a part of this Amendment for any other
purpose.

[The remainder of this page intentionally left blank]

3

 

          IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their
respective officers thereunto duly authorized as of the date first written above.

	 	 	 	 	 	 	 

	 	 	NMC FUNDING CORPORATION,	 	 
	 	 	as Purchaser	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Mark Fawcett
 

	 	 
	 	 	Name: Mark Fawcett	 	 
	 	 	Title: Vice President & Treasurer	 	 
	 
	 	 	 	 	 	 
	 	 	NATIONAL MEDICAL CARE, INC.,	 	 
	 	 	as Seller	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Mark Fawcett
 

	 	 
	 	 	Name: Mark Fawcett	 	 
	 	 	Title: Vice President & Treasurer	 	 

Signature Page

Amendment No. 3 to Amended and Restated Receivables Purchase Agreement

 

 

Exhibit 1
to Amendment

EXHIBIT F

to

AMENDED AND RESTATED

RECEIVABLES PURCHASE AGREEMENT

LIST OF ACTIONS AND SUITS

Such actions and suits as are identified in the “Legal Proceedings” section of the most recent
annual report as of the date hereof on Form 20-F or report on Form 6-K for the quarter most
recently ended prior to the date hereof, as applicable, filed by Fresenius Medical Care AG & Co.
KGaA with the U.S. Securities and Exchange Commission (“SEC”) under the Securities Exchange Act of
1934, which sections are hereby incorporated by reference as if fully set forth herein.

Such filings can be found on the SEC website at the following link:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001333141&owner=exclude&count=40

 

 

Exhibit 2
to Amendment

EXHIBIT J

to

AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

LIST OF TRANSFERRING AFFILIATES, CHIEF EXECUTIVE

OFFICES OF TRANSFERRING AFFILIATES AND TRADENAMES

SECTIONS 2.7(b), 3.1(i) and 3.1(k)(iv)

APHERESIS CARE GROUP, INC.

BIO MEDICAL APPLICATIONS MANAGEMENT COMPANY, INC.

BIO-MEDICAL APPLICATIONS OF ALABAMA, INC.

BIO-MEDICAL APPLICATIONS OF AMARILLO, INC.

BIO-MEDICAL APPLICATIONS OF ANACOSTIA, INC.

BIO-MEDICAL APPLICATIONS OF AQUADILLA, INC.

BIO-MEDICAL APPLICATIONS OF ARECIBO, INC.

BIO-MEDICAL APPLICATIONS OF ARKANSAS, INC.

BIO-MEDICAL APPLICATIONS OF BAYAMON, INC.

BIO-MEDICAL APPLICATIONS OF BLUE SPRINGS, INC

BIO-MEDICAL APPLICATIONS OF CAGUAS, INC.

BIO-MEDICAL APPLICATIONS OF CALIFORNIA, INC.

BIO-MEDICAL APPLICATIONS OF CAMARILLO, INC.

BIO-MEDICAL APPLICATIONS OF CAPITOL HILL, INC.

BIO-MEDICAL APPLICATIONS OF CAROLINA, INC.

BIO-MEDICAL APPLICATIONS OF CARSON, INC.

BIO-MEDICAL APPLICATIONS OF CLINTON, INC.

BIO-MEDICAL APPLICATIONS OF COLUMBIA HEIGHTS, INC.

BIO-MEDICAL APPLICATIONS OF CONNECTICUT, INC.

BIO-MEDICAL APPLICATIONS OF DELAWARE, INC.

BIO-MEDICAL APPLICATIONS OF DOVER, INC.

BIO-MEDICAL APPLICATIONS OF EUREKA, INC.

BIO-MEDICAL APPLICATIONS OF FAYETTEVILLE, INC.

BIO-MEDICAL APPLICATIONS OF FLORIDA, INC.

BIO-MEDICAL APPLICATIONS OF FREMONT, INC.

BIO-MEDICAL APPLICATIONS OF FRESNO, INC.

BIO-MEDICAL APPLICATIONS OF GEORGIA, INC.

BIO-MEDICAL APPLICATIONS OF GUAYAMA, INC.

BIO-MEDICAL APPLICATIONS OF HUMACAO, INC.

BIO-MEDICAL APPLICATIONS OF ILLINOIS, INC.

BIO-MEDICAL APPLICATIONS OF INDIANA, INC.

BIO-MEDICAL APPLICATIONS OF KANSAS, INC.

BIO-MEDICAL APPLICATIONS OF KENTUCKY, INC.

BIO-MEDICAL APPLICATIONS OF LONG BEACH, INC.

 

 

BIO-MEDICAL APPLICATIONS OF LOS GATOS, INC.

BIO-MEDICAL APPLICATIONS OF LOUISIANA, LLC

BIO-MEDICAL APPLICATIONS OF MAINE, INC.

BIO-MEDICAL APPLICATIONS OF MANCHESTER, INC.

BIO-MEDICAL APPLICATIONS OF MARYLAND, INC.

BIO-MEDICAL APPLICATIONS OF MASSACHUSETTS, INC.

BIO-MEDICAL APPLICATIONS OF MAYAGUEZ, INC.

BIO-MEDICAL APPLICATIONS OF MICHIGAN, INC.

BIO-MEDICAL APPLICATIONS OF MINNESOTA, INC.

BIO-MEDICAL APPLICATIONS OF MISSION HILLS, INC.

BIO-MEDICAL APPLICATIONS OF MISSISSIPPI, INC.

BIO-MEDICAL APPLICATIONS OF MISSOURI, INC.

BIO-MEDICAL APPLICATIONS OF NEVADA, INC

BIO-MEDICAL APPLICATIONS OF NEW HAMPSHIRE, INC.

BIO-MEDICAL APPLICATIONS OF NEW JERSEY, INC.

BIO-MEDICAL APPLICATIONS OF NEW MEXICO, INC.

BIO-MEDICAL APPLICATIONS OF NORTH CAROLINA, INC.

BIO-MEDICAL APPLICATIONS OF NORTHEAST, D.C., INC.

BIO-MEDICAL APPLICATIONS OF OAKLAND, INC.

BIO-MEDICAL APPLICATIONS OF OHIO, INC.

BIO-MEDICAL APPLICATIONS OF OKLAHOMA, INC.

BIO-MEDICAL APPLICATIONS OF PENNSYLVANIA, INC.

BIO-MEDICAL APPLICATIONS OF PONCE, INC.

BIO-MEDICAL APPLICATIONS OF PUERTO RICO, INC.

BIO-MEDICAL APPLICATIONS OF RHODE ISLAND, INC.

BIO-MEDICAL APPLICATIONS OF RIO PIEDRAS, INC.

BIO-MEDICAL APPLICATIONS OF SAN ANTONIO, INC.

BIO-MEDICAL APPLICATIONS OF SAN GERMAN, INC.

BIO-MEDICAL APPLICATIONS OF SAN JUAN, INC.

BIO-MEDICAL APPLICATIONS OF SOUTH CAROLINA, INC.

BIO-MEDICAL APPLICATIONS OF SOUTHEAST WASHINGTON, INC.

BIO-MEDICAL APPLICATIONS OF TENNESSEE, INC.

BIO-MEDICAL APPLICATIONS OF TEXAS, INC.

BIO-MEDICAL APPLICATIONS OF THE DISTRICT OF COLUMBIA, INC.

BIO-MEDICAL APPLICATIONS OF UKIAH, INC.

BIO-MEDICAL APPLICATIONS OF VIRGINIA, INC.

BIO-MEDICAL APPLICATIONS OF WEST VIRGINIA, INC.

BIO-MEDICAL APPLICATIONS OF WISCONSIN, INC.

BIO-MEDICAL APPLICATIONS OF WOONSOCKET, INC.

BIO-MEDICAL APPLICATIONS OF WYOMING, LLC

BREVARD COUNTY DIALYSIS, LLC

CLAYTON COUNTY DIALYSIS, LLC

CLERMONT DIALYSIS CENTER, LLC

COLUMBUS AREA RENAL ALLIANCE, LLC

CONEJO VALLEY DIALYSIS, INC.

DIALYSIS AMERICA GEORGIA, LLC

2

 

DIALYSIS ASSOCIATES OF NORTHERN NEW JERSEY, L.L.C.

DIALYSIS ASSOCIATES, LLC

DIALYSIS CENTERS OF AMERICA ILLINOIS, INC.

DIALYSIS MANAGEMENT CORPORATION

DIALYSIS SERVICES OF ATLANTA, INC.

DIALYSIS SERVICES OF CINCINNATI, INC.

DIALYSIS SERVICES OF SOUTHEAST ALASKA, LLC

DIALYSIS SERVICES, INC.

DIALYSIS SPECIALISTS OF MARIETTA, LTD.

DIALYSIS SPECIALISTS OF TOPEKA, INC.

DIALYSIS SPECIALISTS OF TULSA, INC.

DOUGLAS COUNTY DIALYSIS, LLC

DOYLESTOWN ACUTE RENAL SERVICES, L.L.C.

DU PAGE DIALYSIS, LTD.

EVEREST HEALTHCARE HOLDINGS, INC.

EVEREST HEALTHCARE INDIANA, INC.

EVEREST HEALTHCARE OHIO, INC.

EVEREST HEALTHCARE RHODE ISLAND, INC.

EVEREST HEALTHCARE TEXAS HOLDING CORP.

EVEREST HEALTHCARE TEXAS, L.P.

FMS DELAWARE DIALYSIS, LLC

FMS PHILADELPHIA DIALYSIS, LLC

FONDREN DIALYSIS CLINIC, INC.

FORT SCOTT REGIONAL DIALYSIS CENTER, INC.

FOUR STATE REGIONAL DIALYSIS CENTER, INC.

FRESENIUS HEALTH PARTNERS CARE SYSTEMS, INC. (F/K/A RENAISSANCE HEALTH CARE, INC.)

FRESENIUS HEALTH PARTNERS, INC. (F/K/A FRESENIUS MEDICAL CARE HEALTH PLAN, INC.)

FRESENIUS MANAGEMENT SERVICES, INC.

FRESENIUS MEDICAL CARE APHERESIS SERVICES, LLC

FRESENIUS MEDICAL CARE COMPREHENSIVE CKD SERVICES, INC.

FRESENIUS MEDICAL CARE HARSTON HALL, LLC

FRESENIUS MEDICAL CARE HEALTHCARE RECRUITMENT, LLC

FRESENIUS MEDICAL CARE HOLDINGS, INC.

FRESENIUS MEDICAL CARE OF ILLINOIS, LLC

FRESENIUS MEDICAL CARE OF MONTANA, LLC

FRESENIUS MEDICAL CARE — OSUIM KIDNEY CENTERS, LLC

FRESENIUS MEDICAL CARE PHARMACY SERVICES, INC.

FRESENIUS MEDICAL CARE PSO, LLC

FRESENIUS MEDICAL CARE RX, LLC

FRESENIUS MEDICAL CARE — SOUTH TEXAS KIDNEY, LLC

FRESENIUS MEDICAL CARE VENTURES HOLDING COMPANY, INC.

FRESENIUS MEDICAL CARE VENTURES, LLC

FRESENIUS MEDICAL CARE DIALYSIS SERVICES COLORADO LLC (F/K/A BIO MEDICAL APPLICATIONS OF COLORADO, INC.

3

 

FRESENIUS MEDICAL CARE DIALYSIS SERVICES OREGON, LLC

FRESENIUS USA MANUFACTURING, INC.

FRESENIUS USA MAKETING, INC.

FRESENIUS USA, INC

FRESENIUS VASCULAR CARE, INC. (F/K/A NATIONAL VASCULAR CARE, INC.

GULF REGION MOBILE DIALYSIS, INC.

HAEMO-STAT, INC.

HEALTH IT SERVICES GROUP, LLC

HENRY DIALYSIS CENTER, LLC

HOLTON DIALYSIS CLINIC, LLC

HOME DIALYSIS OF AMERICA, INC.

HOME DIALYSIS OF MUHLENBERG COUNTY, INC.

HOMESTEAD ARTIFICIAL KIDNEY CENTER, INC.

INLAND NORTHWEST RENAL CARE GROUP, LLC

INTEGRATED RENAL CARE OF THE PACIFIC, LLC

JEFFERSON COUNTY DIALYSIS, INC.

KDCO, INC.

KENTUCKY RENAL CARE GROUP, LLC

LAWTON DIALYSIS, INC.

LITTLE ROCK DIALYSIS, INC.

MAUMEE DIALYSIS SERVICES, LLC

METRO DIALYSIS CENTER — NORMANDY, INC.

METRO DIALYSIS CENTER — NORTH, INC.

MIAMI REGIONAL DIALYSIS CENTER, INC.

MICHIGAN HOME DIALYSIS CENTER, INC.

NATIONAL MEDICAL CARE, INC.

NATIONAL NEPHROLOGY ASSOCIATES MANAGEMENT COMPANY OF TEXAS, INC

NATIONAL NEPHROLOGY ASSOCIATES OF TEXAS, L.P.

NEPHROMED LLC

NEW YORK DIALYSIS SERVICES, INC.

NMC SERVICES, INC.

NNA MANAGEMENT COMPANY OF KENTUCKY, INC.

NNA MANAGEMENT COMPANY OF LOUISIANA, INC.

NNA OF ALABAMA, INC.

NNA OF EAST ORANGE, L.L.C.

NNA OF FLORIDA, LLC

NNA OF GEORGIA, INC.

NNA OF HARRISON, L.L.C.

NNA OF LOUISIANA, LLC

NNA OF NEVADA, INC.

NNA OF OKLAHOMA, INC.

NNA OF OKLAHOMA, L.L.C.

NNA OF RHODE ISLAND, INC.

NNA OF TOLEDO, INC.

NNA-SAINT BARNABAS LIVINGSTON, L.L.C.

NNA-SAINT BARNABAS, L.L.C.

4

 

NORCROSS DIALYSIS CENTER, LLC

NORTH BUCKNER DIALYSIS CENTER, INC.

NORTHEAST ALABAMA KIDNEY CLINIC, INC.

NORTHERN NEW JERSEY DIALYSIS, L.L.C.

PHYSICIANS DIALYSIS COMPANY, INC.

QUALICENTERS, INC.

QUALICENTERS ALBANY, LTD.

QUALICENTERS BEND, LLC

QUALICENTERS COOS BAY, LTD.

QUALICENTERS EUGENE-SPRINGFIELD LTD.

QUALICENTERS INLAND NORTHWEST LLC

QUALICENTERS PUEBLO, LLC

QUALICENTERS SALEM, LLC

QUALICENTERS SIOUX CITY LLC

RCG BLOOMINGTON, LLC

RCG EAST TEXAS, LLP

RCG INDIANA, L.L.C.

RCG IRVING, LLP

RCG MARTIN, LLC

RCG MEMPHIS EAST, LLC

RCG MEMPHIS, LLC

RCG MISSISSIPPI, INC.

RCG PENSACOLA, LLC

RCG ROBSTOWN, LLP

RCG UNIVERSITY DIVISION, IN.

RCG WEST HEALTH SUPPLY, L.C

RENAL CARE GROUP ALASKA, INC.

RENAL CARE GROUP EAST, INC.

RENAL CARE GROUP MICHIGAN, INC.

RENAL CARE GROUP NORTHWEST, INC.

RENAL CARE GROUP OF THE MIDWEST, INC.

RENAL CARE GROUP OF THE OZARKS, LLC

RENAL CARE GROUP OF THE ROCKIES, LLC

RENAL CARE GROUP OF THE SOUTH, INC.

RENAL CARE GROUP OF THE SOUTHEAST, INC.

RENAL CARE GROUP OHIO, INC.

RENAL CARE GROUP SOUTHWEST MICHIGAN, LLC

RENAL CARE GROUP SOUTH NEW MEXICO, LLC

RENAL CARE GROUP SOUTHWEST HOLDINGS, INC.

RENAL CARE GROUP SOUTHWEST, L.P.

RENAL CARE GROUP TERRE HAUTE, LLC

RENAL CARE GROUP TEXAS, INC.

RENAL CARE GROUP TOLEDO, LLC

RENAL CARE GROUP WESTLAKE, LLC

RENAL CARE GROUP, INC.

RENAL CARE GROUP-HARLINGEN, L.P.

5

 

RENAL SOLUTIONS, INC.

RENALPARTNERS, INC.

RENEX CORP.

RENEX DIALYSIS CLINIC OF BLOOMFIELD, INC.

RENEX DIALYSIS CLINIC OF BRIDGETON, INC.

RENEX DIALYSIS CLINIC OF CREVE COEUR, INC.

RENEX DIALYSIS CLINIC OF DOYLESTOWN, INC.

RENEX DIALYSIS CLINIC OF MAPLEWOOD, INC.

RENEX DIALYSIS CLINIC OF ORANGE, INC.

RENEX DIALYSIS CLINIC OF PHILADELPHIA, INC.

RENEX DIALYSIS CLINIC OF PITTSBURGH, INC.

RENEX DIALYSIS CLINIC OF SOUTH GEORGIA, INC.

RENEX DIALYSIS CLINIC OF ST. LOUIS, INC.

RENEX DIALYSIS CLINIC OF TAMPA, INC.

RENEX DIALYSIS CLINIC OF UNION, INC.

RENEX DIALYSIS CLINIC OF UNIVERSITY CITY, INC.

RENEX DIALYSIS CLINIC OF WOODBURY, INC.

RENEX DIALYSIS FACILITIES, INC.

ROSS DIALYSIS — ENGLEWOOD, LLC

S.A.K.D.C., INC.

SAINT LOUIS RENAL CARE, LLC

SAN DIEGO DIALYSIS SERVICES, INC.

SANTA BARBARA COMMUNITY DIALYSIS CENTER

SMYRNA DIALYSIS CENTER, LLC

SORB TECHNOLOGY, INC.

SPECTRA DIAGNOSTICS, LLC

SPECTRA EAST, INC.

SPECTRA LABORATORIES, INC.

SPECTRA MEDICAL DATA PROCESSING, LLC

SPECTRA RENAL RESEARCH, LLC

SSKG, INC.

ST. LOUIS REGIONAL DIALYSIS CENTER, INC.

STAT DIALYSIS CORPORATION

STONE MOUNTAIN DIALYSIS CENTER, LLC

STUTTGART DIALYSIS, LLC

TAPPAHANNOCK DIALYSIS CENTER, INC

TERRELL DIALYSIS CENTER, L.L.C.

THREE RIVERS DIALYSIS SERVICES, LLC

U.S. VASCULAR ACCESS HOLDINGS, LLC

WARRENTON DIALYSIS FACILITY, INC.

WEST END DIALYSIS CENTER, INC.

WEST PALM DIALYSIS, LLC

WHARTON DIALYSIS, INC.

WSKC DIALYSIS SERVICES, INC.

6

 

3.1(i) Place of Business: For each Transferring Affiliate, the principal place of business,
chief executive office, and the offices where each Transferring Affiliate keeps
substantially all its Records is 920 Winter Street, Waltham, MA 02451.

	 	 	 

	3.1k(iv) Tradenames:

	 	Fresenius Medical Care North America
	 

	 	Spectra Renal Management
	 

	 	Renal Care Group
	 

	 	National Nephrology Associates
	 

	 	TruBlu Logistics (FUSA Mfg)
	 
	 	 
	Mergers:

	 	On April 2, 2004, Renal Care Group, Inc. completed its
acquisition of National Nephrology Associates, Inc.
	 
	 	 
	 

	 	On March 31, 2006, FMCH completed the acquisition of
Renal Care Group, Inc.
	 
	 	 
	 

	 	On November 29, 2007, FMCH completed the acquisition of Renal
Solutions, Inc.
	 
	 	 
	 

	 	On February 29, 2008, FMCH completed the acquisition of MAX
Well Medical, Inc., which was subsequently merged on April
14, 2009 into its subsidiary, Specialty Care Pharmacy, LLC,
and renamed Fresenius Medical Care Rx, LLC

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}]]